El Hombre Sin Nombre
Madmaxista
La decisión final esta ya más cerca:
www.prnewswire.com
El 27 de Septiembre se reúne la FDA y a finales de año sabremos si finalmente es aprobado o no.
BrainStorm Cell Therapeutics Says US FDA Advisory Panel to Review NurOwn Biologics License Application on Sept. 27
-- BrainStorm Cell Therapeutics said Tuesday that an advisory panel of the US Food and Drug Administration will review the Biologics License Application for its investigational therapy NurOwn for...
www.marketscreener.com
BrainStorm Cell Therapeutics Announces FDA Advisory Committee Meeting to Review NurOwn® Biologics License Application Scheduled for September 27, 2023
/PRNewswire/ -- BrainStorm Cell Therapeutics Inc. (NASDAQ: BCLI), a leading developer of adult stem cell therapeutics for neurodegenerative diseases, today...
www.prnewswire.com
El 27 de Septiembre se reúne la FDA y a finales de año sabremos si finalmente es aprobado o no.
